The Journal of Immunology · 2009 · 74 citations · 29 references
Life SciencesImmunologyPharmacologyAllergyImmunoregulationInflammationAllergic ConditionsAllergic DiseaseCytokine BiologyInflammatory SignalingInnate Immune Signaling PathwaysRespiratory AllergyAirway Inflammation ModulationAllergic Airway InflammationAsthma ModelsAsthma PathophysiologyBronchial Hyperresponsiveness ReductionImmunoregulatory SignalingInflammatory Mediator DysregulationNf-κb Signaling
TNF receptor 1 can activate signaling pathways leading to the activation of NF-kappaB. A20, an NF-kappaB-inducible protein, negatively regulates these signaling pathways and acts as an anti-inflammatory mediator. Therefore, A20 is viewed as a potential therapeutic target for inflammatory disease. In this study, we examined the effect of A20 on an OVA-induced allergic airway inflammation model in mice. We used an adenovirus containing A20 cDNA (Ad-A20) that was delivered intratracheally before OVA challenge. Single administration of Ad-A20 reduced airway inflammatory cell recruitment and peribronchiolar inflammation and suppressed the production of various cytokines in bronchoalveolar fluid. In addition, Ad-A20 suppressed mucus production and prevented the development of airway hyperresponsiveness. The protective effect of Ad-A20 was mediated by the inhibition of the NF-kappaB signaling pathway. Taken together, our results suggest that the development of an immunoregulatory strategy based on A20 may have therapeutic potential for the treatment of allergic asthma.
29
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling
Ingrid E. Wertz, Karen O’Rourke, Honglin Zhou et al. · Nature · 2004 · 1.8K citations
Cytokines in symptomatic asthma airways
David H. Broide, A CUOMO, David Coburn et al. · Journal of Allergy and Clinical Immunology · 1992 · 742 citations
Recruitment of the IKK Signalosome to the p55 TNF Receptor
Si Qing Zhang, Andrew Kovalenko, Giuseppina Cantarella et al. · Immunity · 2000 · 451 citations · Full text